Patent · US Expired

Antitumor antibiotic kedarcidin

US5001112A · kind A · utility

2Cited by

6References

2Claims

0Family size

Assignee

Bristol-Meyers Company · US

Inventors

Sandra J. Hofstead · Middletown, US
James A. Matson · Cheshire, US
Kin S. Lam · Cheshire, US
Salvatore Forenza · Cheshire, US
James A. Bush · Town of DeWitt, US
Koji Tomita · Setagaya, JP

Key dates

Filing date	Mar 17, 1989
Grant date	Mar 19, 1991
Priority date	—
Expiry date	Mar 17, 2009

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Kedarcidin is a protein antitumor antibiotic produced by Streptoalloteichus sp. nov. strain L585-6, ATCC 53650. The antibiotic comprises a non-protein chromophore and a single chain polypeptide having 114 amino acid residues.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.